CD133+ is a previously described marker of CSCs in human colon cancer, though it has been contested, and within this subpopulation CD26+ was described as a marker of human colon cancer CSCs with exclusive metastatic potential [15]. The gene discussed is PROM1; the disease is malignant colon neoplasm.